"10.1371_journal.pone.0138724","plos one","2015-09-25T00:00:00Z","Seong-Ho Koh; Anna C Liang; Yoko Takahashi; Takakuni Maki; Akihiro Shindo; Noriko Osumi; Jing Zhao; Hong Lin; Julie C Holder; Tsu Tshen Chuang; John D McNeish; Ken Arai; Eng H Lo","Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America; Department of Neurology, Hanyang University College of Medicine, Seoul, Korea; Department of Developmental Neuroscience, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan; Regenerative Medicine Discovery Performance Unit, GlaxoSmithKline, Cambridge, Massachusetts, United States of America","Conceived and designed the experiments: SHK NO JZ HL JCH TTC JDM KA EHL. Performed the experiments: SHK ACL YT TM AS JZ HL. Analyzed the data: SHK ACL YT HL JCH TTC KA EHL. Contributed reagents/materials/analysis tools: JZ HL JCH TTC JDM. Wrote the paper: SHK HL JCH TTC JDM KA EHL.","Several authors (JZ, HL, JCH, TTC, and JDM) were employed and paid by Glaxo-Smith-Kline. But this does not alter the authors adherence to PLOS ONE policies on data sharing materials. Isx-9 is not a Glaxo-Smith-Kline compound, and belongs to the public domain.","2015","09","Seong-Ho Koh","SHK",13,TRUE,9,7,8,7,TRUE,TRUE,FALSE,0,NA,FALSE
